a6495400.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549


 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported):  November 2, 2010
 

 
CHINA JO-JO DRUGSTORES, INC.

(Exact name of registrant as specified in Charter)
 
Nevada
 
001-34711
 
98-0557852
(State or other jurisdiction of
incorporation or organization)
 
(Commission File No.)
 
(IRS Employer Identification No.)
 
Room 507-513, 5th Floor, A Building, Meidu Plaza
Gongshu District, Hangzhou, Zhejiang Province
People’s Republic of China

(Address of Principal Executive Offices)
 
 
+86 (571) 88077078 

(Issuer Telephone Number)
 
 
N/A 

 (Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 
 
Item 5.07.  
Submission of Matters to a Vote of Security Holders

On November 2, 2010, the Registrant held its Annual Meeting of Shareholders. Set forth below is a brief description of each matter voted upon at the meeting and the voting results with respect to each matter.

1.
A proposal to elect nine (9) directors to the Registrant’s Board of Directors to hold office until the next annual meeting and until their successors are duly elected and qualified.
 
 
Director’s Name
 
Votes For
 
Votes Withheld
 
 
Lei Liu
 
8,847,088
 
5,465
 
 
Li Qi
 
8,847,088
 
5,465
 
 
Chong’an Jin
 
8,847,938
 
4,615
 
 
Shike Zhu
 
8,848,038
 
4,515
 
 
Marc Thomas Serrio
 
8,847,938
 
4,615
 
 
Bowen Zhao
 
8,847,088
 
5,465
 
 
Yuehai Ke
 
8,847,088
 
5,465
 
 
Shuizhen Wu
 
8,847,938
 
4,615
 
 
Xiaomeng Yu
 
8,847,938
 
4,615
 

2.
A proposal to ratify the appointment of Frazer Frost, LLP (“Frazer Frost”) as the Registrant’s independent registered public accounting firm for its fiscal year ending March 31, 2011.
 
 
For
 
Against
 
Abstentions
 
 
10,228,419
 
99,806
 
4,638
 

3.
A proposal to approve the China Jo-Jo Drugstores, Inc. 2010 Equity Incentive Plan (the “Plan”).

 
For
 
Against
 
Abstentions
 
 
8,490,464
 
320,089
 
42,000
 
 
Pursuant to the foregoing votes, Lei Liu, Li Qi, Chong’an Jin, Shike Zhu, Marc Thomas Serrio, Bowen Zhao, Yuehai Ke, Shuizhen Wu and Xiaomeng Yu were elected to serve as directors, Frazer Frost was ratified as the Registrant’s independent registered public accounting firm, and the Plan was approved.

A copy of the Plan is filed as Exhibit 4.1 to this Current Report on Form 8-K, and the material terms of the Plan are summarized in the Registrant’s definitive proxy statement on Schedule 14A filed with the SEC on October 6, 2010, both of which are incorporated herein by reference.
 
Item 9.01.  
Financial Statements and Exhibits
 
Exhibit
Number
  
Description
     
4.1
 
China Jo-Jo Drugstores, Inc. 2010 Equity Incentive Plan
 
 
 

 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


  China Jo-Jo Drugstores, Inc.
 Date: November 3, 2010
(Registrant)
     
 
By: 
/s/ Lei Liu
    Lei Liu
    Chief Executive Officer